(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

May 07, 2014 7:30 AM - May 09, 2014 1:15 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Drug-Induced Injury of Liver, Heart, Kidney, and Skin: Employing Recent Advances to Improve Patient Safety and Speed Up the Pipeline

Featured

Want to learn more about Drug-Induced Injury of Liver, Heart, Kidney, and Skin: Employing Recent Advances to Improve Patient Safety and Speed Up the Pipeline? You've come to the right site!

Continuing-Education

Learn more

Program Committee

  • William Gregory, PhD
    William Gregory, PhD Senior Director, Safety and Risk Management
    Pfizer Inc, United States
  • Pradip Paul, MD, MS
    Pradip Paul, MD, MS Consultant
    Strategic Pharmacovigilance and Risk Management, United States
  • Scott H. Adler, MD
    Scott H. Adler, MD Senior Medical Director, Translational Patient Safety
    AstraZeneca Pharmaceuticals, United States
  • E. Stewart Geary, MD
    E. Stewart Geary, MD Senior Vice President
    Eisai Co., Ltd., Japan
  • Michael Merz, MD
    Michael Merz, MD Director, Discovery and Investigative Safety
    Novartis Institutes For Biomedical Research, Switzerland
  • Arie Regev, MD
    Arie Regev, MD Chair, Liver and GI Safety Committee
    Eli Lilly and Company , United States
  • John R. Senior, MD
    John R. Senior, MD Associate Director for Science, Office of Surveillance and Epidemiology, CDER
    FDA, United States
  • Frank D. Sistare, PhD
    Frank D. Sistare, PhD Associate Vice President, Investigative Laboratory Sciences
    Merck & Co., Inc., United States
  • Norman Stockbridge, MD, PhD
    Norman Stockbridge, MD, PhD Director, Division of Cardiology and Nephrology, OND, CDER
    FDA, United States
  • Stefan Sultana, MD
    Stefan Sultana, MD Senior Medical Director, Companion Diagnostics
    Novartis Pharmaceuticals Corporation, United States
  • Aliza M. Thompson, MD
    Aliza M. Thompson, MD Clinical Team Leader, Division of Cardiovascular and Renal Products, OND, CDER
    FDA, United States
  • Paul B Watkins, MD
    Paul B Watkins, MD Professor; Director, Hamner-UNC Inst for Drug Safety Sciences
    University of North Carolina At Chapel Hill, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.